ARCHIVES

Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum

This article is from The Cancer Letter archive.

Vol. 09 No. 29 | July 22, 1983

Download PDF Visit The Full Archive

Related Articles

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

DCDDP Final Report; 3,557 Cancers, 90% By Mammography

July 9, 1982

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

ARRA Funding Announcements Listed

April 10, 2009